[Therapy of viral hepatitis].
The therapy of viral hepatitis has great medical and socioeconomic impact. Today chronic viral hepatitis is the most important cause for chronic liver disease, liver cirrhosis, and hepatocellular carcinoma. Hepatitis A and E cause acute courses exclusively whereas infection with the hepatitis B, C, and D virus might result in chronic hepatitis as well. The goal of therapy of chronic viral hepatitis has to be a reduction/normalisation of elevated transaminases, decrease of the serologic parameters of active viral replication, improvement of histology and prevention of complications of chronic hepatitis. The only drug with proven benefit in the treatment of chronic viral hepatitis is interferon alpha. This therapy results in a sustained response in 25 to 40% for hepatitis B and 10 to 25% for hepatitis C infection. New developments under clinical evaluation are Lamivudine and Famciclovir in the treatment of HBV-infection and Ribavirin in combination with INFa for chronic HCV-infection.
Rambusch
E G
EG
Abteilung Gastroenterologie und Hepatologie, Medizinische Hochschule Hannover.
Manns
M P
MP
D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006521:Hepatitis, Chronic / Q000175:diagnosis / Q000628:therapy*; D006525:Hepatitis, Viral, Human / Q000175:diagnosis / Q000628:therapy*; D006801:Humans; D016898:Interferon-alpha / Q000009:adverse effects / Q000627:therapeutic use*; D011379:Prognosis
D000998:Antiviral Agents; D016898:Interferon-alpha